However, long-term assessment on Ki-67 as a prognostic marker has previously only occasionally been referred to in ACC [18, 19], but Beuschlein et al. recently found Ki-67 to be the best prognostic marker for recurrence-free and overall survival in a large cohort from three European countries [17]. The gene discussed is MKI67; the disease is adrenal cortex carcinoma.